Canada Artificial Intelligence in Healthcare Market Size, Trends, Growth & Future Outlook 2033

Market Overview 2025-2033

The Canada artificial intelligence in healthcare market size reached USD 163.80 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,321.44 Million by 2033, exhibiting a growth rate (CAGR) of 36.81% during 2025-2033. The market is expanding due to surging demand for AI-driven diagnostics, personalized medicine, and efficient healthcare workflows. Growth is fueled by government investments, integration of wearable tech, and rising adoption of predictive analytics, making the industry more dynamic, precise, and competitive

Key Market Highlights:

✔️ Rapid digital transformation across healthcare systems is accelerating AI adoption for diagnostics, treatment planning, and patient monitoring

✔️ Increasing government and private investments are supporting AI-driven medical innovations and research

✔️ Growing integration of machine learning in medical imaging, virtual care, and hospital workflow automation is improving clinical outcomes and operational efficiency

Request for a sample copy of the report https://www.imarcgroup.com/canada-artificial-intelligence-in-healthcare-market/requestsample

Canada Artificial Intelligence in Healthcare Market Trends and Drivers:

The Canada Artificial Intelligence in Healthcare Market is undergoing a rapid transformation, catalyzed by emerging regulatory frameworks such as the Artificial Intelligence and Data Act (AIDA). Growing public concern over health data privacy in 2024 prompted Health Canada to fast-track the approval process for AI-powered diagnostic tools, resulting in a 40% increase in the use of artificial intelligence in medical imaging. Strategic funding initiatives like Ontario’s $120 million AI Health Fund are accelerating collaboration between health-tech startups—such as Deep Genomics—and major hospital networks, further driving Canada Artificial Intelligence in Healthcare Market Growth.

One of the fastest-growing segments is remote patient monitoring, which surged by 55% amid rising demand from an aging population and ongoing physician shortages. However, fragmented provincial regulations continue to hinder interoperability, leading many healthcare providers to adopt hybrid cloud systems that comply with both federal and provincial data protection laws. Meanwhile, ethical considerations remain central to policy discussions—especially concerns surrounding algorithmic bias in care delivery to Indigenous communities—spurring increased calls for national oversight heading into 2025.

A significant portion of the Canada Artificial Intelligence in Healthcare Market Size is concentrated in precision oncology. In 2024 alone, AI applications in cancer genomics accounted for 32% of the total market. National efforts like the Pan-Canadian Genome Library are leveraging artificial intelligence to analyze over 500,000 genomic profiles, while maintaining stringent patient privacy protocols. Major pharmaceutical players, including Roche, invested more than $200 million in AI-driven drug discovery platforms tailored to Canada’s ethnically diverse population. Additionally, public health surveillance tools like BlueDot are increasingly using real-world data to predict disease outbreaks such as Lyme disease, though limitations in data sharing between hospitals and academic institutions still present barriers to optimal AI deployment.

Despite strong urban adoption, AI penetration in rural healthcare remains limited—telehealth utilization in remote areas hovered at just 15% in 2024, highlighting persistent infrastructure gaps despite recent broadband initiatives. However, demand for AI-powered surgical robotics is accelerating. Companies like Montreal-based Corindus reported a 60% reduction in procedural errors and a 30% faster patient recovery rate, reinforcing the clinical value of robotics. AI is also reshaping healthcare administration; voice-assisted record-keeping and automated billing systems helped the healthcare system save an estimated $380 million last year. Still, high upfront costs for robotic systems have slowed adoption among smaller hospitals, and cybersecurity threats—such as the recent cyberattacks on Quebec hospitals—have exposed vulnerabilities in AI networks.

Talent retention poses another challenge to Canada Artificial Intelligence in Healthcare Market Growth, with roughly 75% of AI developers reportedly relocating to the U.S., creating a local innovation gap. Nevertheless, strong collaborations between academic institutions, government bodies, and the private sector continue to support market momentum. Key initiatives include Alberta’s $90 million commitment to AI ethics research and faster regulatory approvals for AI tools in radiology.

While the market initially focused on diagnostic applications, the Canada Artificial Intelligence in Healthcare Market Trends now point toward predictive modeling for ICU bed shortages, chronic disease risks, and even resource allocation. Cloud-based AI adoption grew 48% in 2024 alone, driven by hospitals seeking scalable, cost-efficient solutions. Despite ongoing chip shortages delaying medical robotics production, regulatory harmonization with the EU and U.S. is creating new export pathways for Canadian AI innovations.

Looking ahead, the Canada Artificial Intelligence in Healthcare Market Outlook is promising. Emerging developments such as decentralized clinical trials and Indigenous-led health data sovereignty initiatives are setting the stage for equitable, sustainable growth. As Canada balances privacy, innovation, and access, the country is well-positioned to lead in ethical and effective healthcare AI deployment through the coming decade.

Canada Artificial Intelligence in Healthcare Market Segmentation:

The market report segments the market based on product type, distribution channel, and region:

Study Period:

Base Year: 2024

Historical Year: 2019-2024

Forecast Year: 2025-2033

Breakup by Offering:

• Hardware

• Software

• Services

Breakup by Technology:

• Machine Learning

• Context Aware Computing

• Natural Language Processing

• Others

Breakup by Application:

• Robot-Assisted Surgery

• Virtual Nursing Assistant

• Administrative Workflow Assistance

• Fraud Detection

• Dosage Error Reduction

• Clinical Trial Participant Identifier

• Preliminary Diagnosis

• Others

Breakup by End User:

• Healthcare Providers

• Pharmaceutical and Biotechnology Companies

• Patients

• Others

Breakup by Region:

• Ontario

• Quebec

• Alberta

• British Columbia

• Others

Competitive Landscape:

The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145